US Customs and Border Protection rejected recommendations by the CDC to vaccinate migrants in detention centers for the flu; PhRMA cut its donation to Addiction Policy Forum and will end all support in 2020; Louisiana health officials announced they will examine the cancer incidence in an area next to a chemical plant known to emit a likely carcinogen.
Last winter, the CDC recommended the US Customs and Border Protection (CBP) to vaccinate migrants in detention against the flu, but CBP rejected the idea, according to a letter acquired by CNN. In the letter, Robert Redfield, MD, director of the CDC, responded to Rosa DeLaura, US Representative for Connecticut's 3rd congressional district, when being asked if CBP spoke with the CDC about the child deaths at detention centers, if CBP asked for guidance about vaccination for migrants, and if the CDC has spoken with HHS or the White House about CBP vaccination rules. Redfield responded that the CDC has been discussing the issue of child deaths with CBP since the beginning 2018, and spoke weekly with the agency in 2019 about flu cases in migrant facilities from May to July 4.
PhRMA announced it will cut its donation for Addiction Policy Forum (APF) from $8.1 million to $6 million this year and will end all support in 2020, according to Politico. Jessica Nickel, chief executive officer of APF, was accused by 8 current and former employees of having poorly managed some of the millions given in the donation, which currently provides the nonprofit organization with 90% of its funding. Nickel stated, “It is categorically false to claim that we have misused or mismanaged money.”
Louisiana health officials announced their intention to examine every residence within 2.5 kilometers of the chemical plant Denka Performance Elastomer in St. John the Baptist Parish to determine how many people in the neighborhood have developed cancer, according to ProPublica. The area, called Cancer Alley, has long been stressed by residents as concerning due to the amount of chemical plants near their homes, which are known to emit carcinogens and cancer-causing air pollutants. Back in 2010, the Environmental Protection Agency stated that the Denka plant is the only one in the country to emit the classified likely carcinogen chloroprene.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen